Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of RPS6KA1 protein | affects cotreatment|decreases phosphorylation | 16611854
|
C108123 |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of RPS6KA1 protein] | decreases reaction|increases phosphorylation | 15772366
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RPS6KA1 mRNA | affects expression | 17562736
|
C103303 |
alitretinoin |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in decreased phosphorylation of RPS6KA1 protein | affects cotreatment|decreases phosphorylation | 16611854
|
C517975 |
AZD 6244 |
AZD 6244 results in decreased phosphorylation of RPS6KA1 protein | decreases phosphorylation | 17876044
|
C517975 |
AZD 6244 |
Doxorubicin promotes the reaction [AZD 6244 results in decreased phosphorylation of RPS6KA1 protein] | decreases phosphorylation|increases reaction | 17876044
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein | increases phosphorylation | 17003459
|
D020122 |
tert-Butylhydroperoxide |
U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein] | decreases reaction|increases phosphorylation | 17003459
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of RPS6KA1 mRNA | increases expression | 17032414
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of RPS6KA1 protein | increases expression | 17805973
|
C007262 |
deoxynivalenol |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of RPS6KA1 protein] | decreases reaction|increases phosphorylation | 15772366
|
C007262 |
deoxynivalenol |
deoxynivalenol results in increased phosphorylation of and results in increased activity of RPS6KA1 protein | increases activity|increases phosphorylation | 15976193
|
C007262 |
deoxynivalenol |
deoxynivalenol results in increased phosphorylation of RPS6KA1 protein | increases phosphorylation | 15772366
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of RPS6KA1 mRNA | increases expression | 17032414
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of RPS6KA1 protein | increases expression | 17032414
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [AZD 6244 results in decreased phosphorylation of RPS6KA1 protein] | decreases phosphorylation|increases reaction | 17876044
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of RPS6KA1 mRNA | increases expression | 17942748
|
C067431 |
letrozole |
letrozole results in increased expression of and results in increased phosphorylation of RPS6KA1 protein | increases expression|increases phosphorylation | 15967659
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of RPS6KA1 mRNA | decreases expression | 12057914
|
C015329 |
lycopene |
lycopene results in decreased expression of RPS6KA1 protein | decreases expression | 17337101
|
C040015 |
myricetin |
myricetin inhibits the reaction [EGF protein results in increased phosphorylation of RPS6KA1 protein] | decreases reaction|increases phosphorylation | 17693661
|
C040015 |
myricetin |
myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KA1 protein] | decreases reaction|increases phosphorylation | 17693661
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RPS6KA1 mRNA | affects binding|increases activity|increases expression | 19710929
|
C059514 |
resveratrol |
resveratrol results in decreased phosphorylation of RPS6KA1 protein | decreases phosphorylation | 16979140
|
D017975 |
Ruthenium Compounds |
Ruthenium Compounds results in decreased activity of RPS6KA1 protein | decreases activity | 16858717
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA | affects cotreatment|increases expression | 19244175
|
D012643 |
Selenium |
Selenium results in increased expression of RPS6KA1 mRNA | increases expression | 19244175
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RPS6KA1 mRNA | decreases expression | 12760830
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RPS6KA1 protein | decreases expression | 12760830
|
C016104 |
sodium bichromate |
sodium bichromate results in decreased expression of RPS6KA1 mRNA | decreases expression | 12760830
|
D013755 |
Tetradecanoylphorbol Acetate |
myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KA1 protein] | decreases reaction|increases phosphorylation | 17693661
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased phosphorylation of RPS6KA1 protein | increases phosphorylation | 17693661
|
D014212 |
Tretinoin |
RPS6KA1 protein promotes the reaction [Tretinoin results in increased phosphorylation of CREB1 protein] | increases phosphorylation|increases reaction | 16280361
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein] | decreases reaction|increases phosphorylation | 17003459
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA | affects cotreatment|increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.75 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.28 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.68 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.45 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.45 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
6.90 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
6.90 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.90 | 14692618 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
6.77 | 19555203 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.77 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.29 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.51 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.71 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.36 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.46 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.53 | 16162502 16183991 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.65 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.28 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.60 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
11.60 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
11.60 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.22 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.29 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.16 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.22 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.40 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.40 | 16206674 16197459 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.51 | 14601052 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.09 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.64 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.34 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.34 | 17369602 18695136 15668708 15567936 18628466 19526202 16595493 16826403 17426702 15994142 18234424 15692762 16935488 18382427 11325840 15993339 16322301 16096432 17983394 15136595 15634643 16264153 16115903 15939500 |
MESH:D001943 |
Breast Neoplasms |
|
letrozole |
2.34 | 16002280 17892469 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.34 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.34 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.40 | 16813970 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
9.30 | 15673190 18705752 16192424 16124888 3786805 10355542 16227642 16011737 15721981 16097048 15700767 16050911 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
9.30 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.62 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
3.87 | 19555203 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.97 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
13.61 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
AZD 6244 |
13.61 | 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
13.61 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
13.61 | 16023760 18059187 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
13.61 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.61 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.61 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.40 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.07 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
17.36 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
17.36 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
17.36 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
17.36 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
17.36 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
17.36 | 16096774 16051514 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.41 | 16269455 16278810 17928571 15811867 15505089 16612575 16651473 15792986 16731534 17007740 18627295 17329180 15476868 16455267 17924179 17131338 16109756 16364871 17974986 17382496 17308081 16242529 17519947 16952015 17351982 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.88 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.34 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
6.86 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
6.86 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.86 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.40 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.28 | 17110522 17681005 17333356 16105132 11677210 16919318 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.28 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.97 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.59 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
14.95 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
14.95 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
14.95 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.43 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.69 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.69 | 16550006 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.63 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.63 | 16925845 17551590 9142499 10589399 8800419 9211117 9664655 14991402 9224671 9125849 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.63 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.34 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.61 | 16873680 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.80 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.41 | 2444490 16081117 12594235 10663392 16485898 16781746 14986274 19085960 19164858 17906064 10774834 15968718 19420014 19416960 11529661 18713872 19923254 11461765 12958197 19739265 11743745 10915739 12540782 12705907 11739529 11287661 12392966 14725611 16393943 16109766 11421492 18071297 19370779 16177239 14550746 17522070 16227642 17562736 11834606 15619225 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
11.41 | 11566570 10092053 16177239 6884620 7440962 6623471 17522070 15027814 15968718 7179309 2869522 3786805 4309450 15998439 16227642 10915739 9327722 3732212 19085960 7120509 19336974 21278145 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
11.41 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
11.41 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
11.41 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.91 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.53 | 18602426 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.51 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.60 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
10.60 | 8985016 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
10.60 | 15177302 7812673 16716910 9599246 11698051 8273558 8113982 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.27 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
15-deoxy-delta(12,14)-prostaglandin J2 |
14.49 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.49 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
14.49 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.18 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.18 | 16569247 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.96 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.20 | 15821434 17637181 15328337 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.66 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
2.86 | 17016578 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.44 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
12.04 | 61145 15959796 19224547 17595544 12795759 12631006 16045604 16239168 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.04 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.04 | 19236843 20131406 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.85 | 11852909 9205823 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.40 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.18 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.18 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.48 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.49 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.41 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
myricetin |
11.41 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
11.41 | 17312396 |
MESH:D005922 |
Glomerulonephritis, IGA |
|
deoxynivalenol |
4.86 | 16524712 15173396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
7.42 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.42 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.97 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.45 | 9664655 14991402 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.45 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.35 | 17875725 17888722 18006777 16144979 16495754 12587719 16244372 16879835 16707910 16330681 18674790 16244371 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
11.13 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
11.13 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
11.13 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.73 | 15692506 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.22 | 16366002 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.41 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.81 | 19772884 16221962 19176532 18467677 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.64 | 16490937 16863852 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.99 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.95 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.95 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.78 | 14716179 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.13 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.13 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.34 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.83 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.38 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.02 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.85 | 16873680 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.90 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.13 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.62 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.46 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.28 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.22 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.22 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
7.99 | 9205823 17255318 12878042 17237260 17963957 |
MESH:D007249 |
Inflammation |
|
resveratrol |
7.99 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
7.99 | 7812673 8273558 7562506 11698051 15177302 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
17.51 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
17.51 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
17.51 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.51 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.58 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.45 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.73 | 15992940 17551590 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.45 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.56 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
13.56 | 16775033 15369732 15699352 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
13.56 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
13.56 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
9.41 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
9.41 | 16518626 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.68 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.96 | 16085563 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
5.11 | 16972261 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.53 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.05 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.36 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.36 | 16788101 15748426 17107899 17217047 17301526 19225113 16823087 16140955 19642359 16766008 17294898 16331271 16935935 19029980 17649720 17506722 16891316 12679006 19035177 17368321 17339181 17712046 17361223 9834237 19075265 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.51 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.17 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.70 | 11408273 11903743 17334410 17157831 21278145 17174718 16239168 16943688 16221502 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.55 | 15893842 17698563 18481824 20821823 18205269 17481882 18166357 18054572 15730626 16638106 16116963 18420326 18279442 15931870 18317297 18277467 12632512 15959796 12632514 17557913 17708605 18472094 17525996 16033810 16248980 16015684 15338365 16136751 16027843 12445418 18210741 12649538 17944888 18376398 18418968 17869086 12586293 18251166 12667390 16097048 15057751 17714472 18705752 18395914 17721639 14748882 17631135 18472332 17565644 15052691 17640975 17823541 14724832 12666154 15996030 15370692 12741479 14512876 12958196 12546737 18429990 11481614 18156304 17900296 12445421 14716496 17805973 16011737 15362042 18412020 17766677 18395095 10355542 15925388 18339082 15818738 15673190 17922224 13678700 18006644 15123356 14620537 16192424 14716833 15876570 18263696 15650968 12609069 17761835 17976157 18187930 12389079 12898905 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
10.55 | 17201889 16570917 18672772 18567088 15763062 16042886 16169303 15138612 14726149 17640959 18629640 15942678 14709902 12918455 15369754 17719030 18095165 17196135 14643895 15339415 15492853 15733078 14568256 18637143 17432682 15842777 17724770 17465448 16009107 15479170 15571005 18237412 15744066 15099470 17666798 16544323 15864749 18371158 15081153 15086199 17036385 14659978 17203207 16270385 15577212 15798949 15504291 15298665 17198567 15161499 18364076 18210741 17348192 15366600 15723089 17881167 16627068 17534399 16603200 15067225 15793283 12925901 15383259 15591649 18239293 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
10.55 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
10.55 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.55 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.55 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
10.55 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.73 | 19784758 12969438 12587719 16611625 19460945 11587558 19014921 16610002 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.73 | 15720792 17285989 16246199 15830285 16964402 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.97 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
15.30 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
15.30 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
15.30 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
13.48 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
13.48 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.48 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.48 | 20405173 19812893 19073162 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.48 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.33 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
9.33 | 6150874 1848544 15603536 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.33 | 16842330 17085340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.02 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
7.02 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.82 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
8.26 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
8.26 | 11884234 16061637 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
8.26 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.26 | 15276417 16712894 17306315 19931552 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.26 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
8.26 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.33 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.12 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
8.36 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
8.36 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.38 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.06 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
13.34 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
13.34 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
13.34 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
13.34 | 8985016 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.71 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.47 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
9.47 | 17992120 |
MESH:D008545 |
Melanoma |
|
Ruthenium Compounds |
9.47 | 17210701 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.47 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.47 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.38 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.24 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.04 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.04 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.20 | 17112576 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.32 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.60 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.33 | 16267019 17049120 17164350 16490592 17935668 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.68 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.32 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
2.97 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.05 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.05 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
9.05 | 17015251 16317513 17188708 17125593 16525036 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
3.86 | 17125593 17015251 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.80 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.57 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.88 | 18259882 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
14.76 | 16946489 |
MESH:D009369 |
Neoplasms |
|
lycopene |
14.76 | 17051425 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
14.76 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
14.76 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
14.76 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.60 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.60 | 20056578 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.58 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.84 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.59 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.90 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.90 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.17 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.84 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.84 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.22 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.77 | 20558911 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.08 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.96 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.68 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.68 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
7.68 | 16211241 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.08 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.08 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.28 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.28 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.51 | 11578682 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
4.11 | 12065085 18404319 18922899 8330346 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.96 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.70 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.96 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.36 | 12224865 11605937 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.81 | 16144296 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
3.99 | 16679765 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.91 | 18437689 15749863 15897917 16888761 16868541 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
1.91 | 17337101 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.91 | 17636462 16731767 17804756 15767336 17675339 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.91 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
1.91 | 15084515 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.43 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.12 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.60 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.03 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.39 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.26 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.26 | 17520802 17058453 16317513 16314181 15827377 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.61 | 10835634 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.92 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.82 | 15625365 17203757 16767912 18313854 15675481 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.06 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.60 | 17846226 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.39 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
21.33 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
21.33 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
21.33 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
21.33 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
21.33 | 8330346 12065085 18404319 11807781 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
21.33 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.38 | 15625365 16767912 17203757 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.75 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.65 | 12854658 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
5.08 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
2.63 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.63 | 17261132 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.37 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.31 | 16321402 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.00 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.44 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.99 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
11.43 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.43 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.43 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
9.35 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.35 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.11 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.02 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.02 | 16452187 11723127 17306315 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.80 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
14.92 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.92 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.92 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.89 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.89 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.42 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.23 | 17056641 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
9.71 | 17678736 17334414 17638931 16364871 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
9.71 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.87 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.81 | 16287080 |